Topical therapy is the major treatment approach for patients with psor
iasis. However, the effectiveness of available drugs (response rates a
nd long-term maintenance) is not well known. This study investigated t
he current perceptions of American dermatologists on the effectiveness
of topical medications for patients with mild or limited psoriasis. I
n a survey of 225 American dermatologists, class I to II topical stero
ids were regarded as most effective: 29 percent of dermatologists expe
cted most of their patients to experience clearing of lesions when tre
ated with these agents, Much lower response rates were found with medi
um and low-potency steroids, anthralin, or tars. The percentage of pat
ients whose skin remained clear of lesions decreased to 50 percent whi
le receiving maintenance corticosteroid therapy by three months and to
29 percent after one year. Topical corticosteroids were considered le
ss effective than the available photo/systemic therapies by 79 percent
of physicians. More effective topical modalities need to be developed
to treat patients with mild/limited psoriasis.